Daniel O’Connor has resigned as CEO of Advaxis. The cancer immunotherapy biotech has put CBO Tony Lombardo in charge while it searches for a permanent successor to O’Connor. Advaxis provided scant ...
Although we don't believe intiming the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...
When perusing the biotech sector, investors have more than 300 publicly traded companies on reputable exchanges that they can choose from. It's almost overwhelming, and it can make finding a company ...
Add Yahoo as a preferred source to see more of our stories on Google. By Vidya L Nathan (Reuters) - Advaxis Inc said its experimental cancer vaccine was found more effective in improving survival ...
Because a number of shareholders had expressed concern that the apparent success of the Merck drug diminished the potential role of Lovaxin C.Princeton-based Advaxis (Nasdaq: ADXS) has issued ...
PRINCETON, N.J.--(BUSINESS WIRE)-- Advaxis, Inc., (OTCBB: ADXS) ("Advaxis" or the "Company"), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, ...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in ...
Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer
MONMOUTH JUNCTION, N.J., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy ...
What: After reporting intriguing data for its cancer therapy in dogs that could have implications for human cancer patients, shares in Advaxis, (ADXS +0.00%) are rallying 15% at 2:00 p.m. EST Monday.
We are just a few weeks into the year, and already shares of Advaxis ( ADXS) are up by more than 60%. But that's nothing. The shares have fully quadrupled since their November lows. Advaxis stock has ...
REHOVOT, Israel and WILMINGTON, Del. and MONMOUTH JUNCTION, N.J., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS), a biotechnology company devoted to the discovery, development and ...
Advaxis Inc., a Princeton biotech specializing in drugs treating cancer and infectious diseases, today named Daniel J. O’Connor as CEO, replacing Thomas Moore, who will continue to serve on the board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results